DNA Funded vs ThinkCapital (2026) — Which Is Better?
Compare DNA Funded and ThinkCapital — features, pricing, pros and cons.
Numbers, fees, and platform capabilities cited here come from each vendor's public documentation. Confirm current pricing before you commit. Methodology →
Quick Verdict
Higher Rated
ThinkCapital (4.0)
More Affordable
ThinkCapital ($39/mo)
DNA Funded
Australian broker-backed prop firm offering 1-Phase, 2-Phase, Rapid, and Instant Funding challenges with 80% profit splits and 800+ CFD instruments via TradeLocker.
ThinkCapital
ThinkCapital is a prop firm backed by regulated broker ThinkMarkets, offering 1-, 2-, and 3-step challenges across 4,000+ instruments with up to 90% profit splits.
Rules, Payout & Fee Breakdown
| Feature | DNA Funded | ThinkCapital |
|---|---|---|
| Rating | ★ 3.9 | ★ 4.0 |
| Starting Price | $49/mo | $39/mo |
| Free Tier | No | No |
| Markets | forex, indices, commodities, stocks, crypto | forex, indices, commodities, crypto, etfs |
| AI Analysis | ✗ | ✗ |
| Backtesting | ✗ | ✓ |
| Paper Trading | ✗ | ✓ |
| Price Alerts | ✗ | ✓ |
| Mobile App | ✓ | ✓ |
| API Access | ✗ | ✓ |
| Social Features | ✗ | ✗ |
| Broker Integration | ✓ | ✓ |
| Custom Indicators | ✗ | ✓ |
| Automated Trading | ✗ | ✓ |
| Trade Journaling | ✗ | ✗ |
| Performance Analytics | ✓ | ✓ |
| Risk Management | ✓ | ✓ |
| News Feed | ✗ | ✓ |
| Education Content | ✗ | ✓ |
Prop-Firm Head-to-Head
DNA Funded and ThinkCapital both launched in 2024 but target different trader priorities. DNA Funded emphasizes regulatory credibility through ASIC-backed broker integration and operational simplicity—offering four challenge types with no time limits and refundable fees at $49/month. ThinkCapital positions itself as the instrument-access leader, providing 4,000+ tradeable assets (forex, crypto, commodities, ETFs) against DNA's 800 CFDs, alongside platform flexibility through TradingView and MT5 at $39/month.
The critical differentiator is DNA Funded's Instant Funding pathway and raw spread model (0.0 pips minimum), designed for experienced traders ready to skip evaluation entirely. ThinkCapital counters with regulatory depth—FCA, ASIC, and CySEC licenses—and a proven parent broker (ThinkMarkets, 10+ years), though the 90% profit split requires a paid add-on, effectively raising the cost above its stated $39/month.
DNA Funded suits scalpers and spread-sensitive traders, especially those in Australia seeking regulatory confidence. ThinkCapital appeals to multi-asset traders needing crypto exposure, TradingView integration, or those comfortable with a longer scaling path to $1.5M. Neither offers futures yet, so options-focused traders should look elsewhere.
DNA Funded: Pros & Cons
Pros
- + Backed by ASIC-regulated DNA Markets broker — rare and credible among prop firms
- + No time limits on 1-Phase and 2-Phase challenges
- + Raw spreads from 0.0 pips with 800+ CFD instruments
- + Four challenge types including Instant Funding for traders who want to skip evaluation
- + Challenge fee refunded upon first payout
Cons
- - Founded in 2024 with limited track record and community history
- - Futures and options trading not yet available
- - Crypto trading excluded from the Rapid challenge
- - Affiliate commission rates not publicly disclosed
ThinkCapital: Pros & Cons
Pros
- + Backed by ThinkMarkets, a multi-regulated broker (FCA, ASIC, CySEC) with 10+ years of operating history
- + Three challenge formats (1-step, 2-step, 3-step) accommodate different trading styles and risk tolerances
- + 4,000+ tradeable instruments spanning forex, indices, commodities, crypto, and ETFs
- + TradingView integration and MT5 support alongside the proprietary ThinkTrader platform
- + Scaling path up to $1.5M allocated capital with frequent 25–40% promotional discounts
Cons
- - Founded July 2024 — very limited long-term payout track record to evaluate
- - 90% profit split requires a paid add-on costing approximately 25% more than the base challenge fee
- - Lightning plan's 6% trailing drawdown is tighter than most competitors and can catch active traders
- - No futures or exchange-traded options — all instruments are CFD-based only